The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Nvidia is no longer content to be the chip supplier behind other companies’ biotech ambitions. With a multibillion dollar ...

Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.

Insilico Medicine and Qilu Pharmaceutical Group announced a strategic collaboration to jointly develop small-molecule inhibitors for cardiometabolic diseases, combining Insilico’s generative AI–driven ...

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

DUBLIN--(BUSINESS WIRE)--The "AI in Biotechnology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for AI in biotechnology was valued at $3.8 billion in ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

The companies will invest up to $1 billion over five years to support discovery and development powered by artificial ...

Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules ...

Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Drug Discovery & Development Virtual Event on February ...